Published May, 2020
By Arie Perry and Sylvia L. Asa
Publisher: American Registry of Pathology
Rating:
in-stock

Builds on the work that was presented in the previous Fascicles of the Third and Fourth Series. This updated volume addresses modern techniques and their application to treatment of pituitary neoplasms but retains the detailed foundation of morphology in a lushly illustrated tome, the cornerstone of the AFIP fascicles.

---

Published April, 2020
By Sylvia Asa and Tim-Rasmus Kiehl
Publisher: American Registry of Pathology
Rating:
in-stock

---

Published August, 2019
By Robert A. Soslow, Esther Oliva, David C. Wilbur and Neil J. Sebire
Publisher: American Registry of Pathology
Rating: 1.00
in-stock

Provides thorough, concise, and up-to-date information on the nomenclature and classification; epidemiologic, clinical, and pathogenetic features; and, most importantly, guidance in the diagnosis of the tumors and tumorlike lesions of all major organ systems and body sites.

---

Published May, 2019
By Andrew G. Nicholson, William D. Travis, Kim R. Geisinger and Elisabeth Brambilla
Publisher: American Registry of Pathology
Rating:
in-stock

Remarkable advances have occurred since the Series 3 Fascicle published in 1995 with paradigm shifts in every dimension of our understanding of lung tumors including clinical, radiologic, histopathologic, cytopathologic, immunohistochemical, molecular and therapeutic aspects.

---

Published February, 2019
By Elizabeth A Montgomery, Jason L. Hornick, Robert D. Odze, Joel K. Greenson, Gregory Y. Lauwers, Fatima Carneiro and Helen H. Wang
Publisher: American Registry of Pathology
Rating:
in-stock

Advances in many areas of tumor biology have led to a better understanding of the pathogenesis, pathology, and molecular biology of epithelial and stromal malignancies of the upper gastrointestinal tract. This edition highlights these advances, and helps pathologists diagnose diseases more accurately.

---

Published September, 2018
By Michael Torbenson, Yoh Zen and Matthew M. Yeh
Publisher: American Registry of Pathology
Rating:
in-stock

Numerous advances in our understanding of the pathology and molecular features of liver tumors have been made since the publication of the previous series, nearly two decades ago. Together with the more unified classification and terminology of intrahepatic bile duct tumors and their precursors, these advances call for updated information that is presented in this volume.

---

Published October, 2017
By Elizabeth A Montgomery, Rhonda K. Yantiss, Dale C. Snover and Laura H. Tang
Publisher: American Registry of Pathology
Rating:
in-stock

While many areas of intestinal tumour pathology are without controversy, the classification and nomenclature for appendiceal tumours remain a subject of debate. This volume offers information on the various divergent viewpoints where they exist for this topic and others.

---

Published October, 2017
By Dennis P. O'Malley, L. Jeffrey Medeiros, Nancy P. Caraway, Francisco Vega, Kojo S. J. Elenitoba-Johnson and Megan S. Lim
Publisher: American Registry of Pathology
Rating:
in-stock

The understanding of diagnostic lymph node and spleen pathology has evolved at an impressive pace since 1995, when the third series AFIP atlas was published. This atlas will provide readers with the comprehensive information necessary for the pathological and clinical assessment of lymph node and splenic lesions.

---

Published June, 2017
By Bruce M. Wenig, Mary S. Richardson, Lester D. R. Thompson, Raja R. Seethala and Esther L. B. Childers
Publisher: American Registry of Pathology
Rating:
in-stock

Offers a broad overview of the spectrum of diseases involving the sinonasal tract, oral cavity, pharynx, larynx, neck, salivary glands, and ear and temporal bone. The book focuses primarily on the more common non-neoplastic head and neck diseases that the surgical pathologist will confront in their daily practice.

---

Published September, 2016
By Kathryn Foucar, Steven H. Kroft, LoAnn C. Peterson and Robert W. McKenna
Publisher: American Registry of Pathology
Rating:
in-stock

Highights the immunophenotypic and molecular genetic tests of greatest value in diagnoses, risk assessment, and disease monitoring. The focus on molecular genetic findings for each neoplasm parallels the ever-expanding role of genetics in disease classification and risk assessment. Key problem areas and differential diagnostic considerations are also included for each neoplastic disease category.

---